Navigation Links
Heart Failure Society of America And The American Association of Heart Failure Nurses Release Joint Statement

SEATTLE, Sept. 10, 2012 /PRNewswire/ -- The 16th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) opened today at the Washington State Convention Center in Seattle. The program will feature presentations and seminars on the latest issues and treatments from leading heart failure experts.

At this year's conference, HFSA and the American Association of Heart Failure Nurses (AAHFN) will release a joint statement regarding the role of nursing in the care of persons with heart failure.

"HFSA and AAHFN share a common mission to improve outcomes of patients with heart failure," said Dr. Barry Massie, M.D., president of HFSA. "Heart failure is the fastest growing cardiovascular disease in the United States, and effective treatment of this disease requires a team of experts from many disciplines practicing to their full abilities."

The statement strongly advocates for the removal of scope-of-practice barriers for nurses, which would allow nurses to practice to the full extent of their educational training. Also, HFSA and AAHFN endorse recent recommendations to make nurses full partners in the redesign of healthcare.  Because of their role in the treatment of patients, nurses have invaluable insight into the delivery of healthcare. 

"Nurses are in a key position to prevent complications, recognize symptoms and tailor treatment strategies for heart failure patients," said Linda Baas, President of AAHFN.  "Unfortunately, in many parts of the United States, nurses are not allowed to practice at the full level of their training. This joint statement with HFSA emphasizes our common position, and hopefully begins to change the role of nurses in heart failure care and treatment."

For a complete list of annual meeting sessions or for details on attending the conference, call (617) 226-7183 or visit and click on Annual Scientific Meeting. There is no registration fee for accredited journalists. Interview areas will be available on-site in addition to a fully-staffed press room with phone and internet accessibility. You may follow news from the meeting on Twitter @HFSA and #HFSA.

About Heart Failure
Heart failure is a progressive condition in which the heart muscle becomes weakened after it is injured, most commonly from heart attack or high blood pressure, and gradually loses its ability to pump enough blood to supply the body's needs. Many people are not aware they have heart failure because the symptoms are often mistaken for signs of getting older. Heart failure affects 4.6 to 4.8 million individuals in the United States. Demographic and clinical evidence strongly suggests that the prevalence of heart failure will increase throughout the next decade. Ten to 15 years ago heart failure was considered a "death sentence;" however, recent advances in treatment have shown that early diagnosis and proper care in early stages of the condition are key to slowing, stopping or in some cases reversing progression, improving quality of life, and extending life expectancy. For more information on heart failure, please visit

About the Heart Failure Society of America
The Heart Failure Society of America (HFSA) is a nonprofit educational organization, founded in 1994 as the first organized association of heart failure experts. The HFSA provides a forum for all those interested in heart function, heart failure research and patient care. The Society also serves as a resource for governmental agencies (FDA, NIH, NHLBI, CMS). The HFSA Annual Scientific Meeting is designed to highlight recent advances in the development of strategies to address the complex epidemiological, clinical and therapeutic issues of heart failure. Additional information on HFSA can be found at

SOURCE Heart Failure Society of America
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
2. Retired Pro Hockey Player 1st to Receive Total Artificial Heart in Upstate New York
3. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
4. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
5. Heartware Schedules First Quarter Conference Call And Webcast
6. Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012
7. Stereotaxis Epoch™ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
8. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
9. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
10. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
11. Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):